MedPanel Announces New Integrated Product Suite
Cambridge, MA, September 22, 2004 – MedPanel, a leader in online medical market intelligence for companies with a stake in life sciences, today announced realignments and enhancements to its product suite, designed to give clients one of the most robust offerings of qualitative, quantitative and syndicated products in medical market research. The changes are part of MedPanel’s strategy to lead the market with the most comprehensive product line and clinical research expertise in the industry.The integrated product suite is built from MedPanel’s proprietary online methodology that enables life sciences companies rapid and easy access to physicians and other medical professionals in order to gain valuable insights into the clinical issues that affect drug and device development and commercialization.
Product Strategy
“Clients told us that they wanted a single provider for their market research, one who understands their business and can meet all their research needs and has the relationships to provide them with easy access to key opinion leaders,” said Will Febbo, MedPanel’s chief executive officer. “We responded with this comprehensive set of products that range from one-on-one exchange with a physician to multi-party clinical trial design studies. We plan to introduce several additional products that target other sectors of the economy during 2005.” he added.
Positioned to Lead and Partner
“With this strategic change, MedPanel is positioned to become the leading market research provider in the life sciences. Our clinical knowledge, technical expertise and market experience are second to none, and we remain the only full-service online provider of medical market research,” concluded Mr. Febbo.
To better deliver these products and serve its clients, MedPanel has re-aligned its operations, giving more strategic importance to product development. Matt Fearer, senior vice president, will work closely with Will Febbo to oversee the new product development strategy.
MedPanel’s unique online approach permits physicians and clinicians the freedom to participate in a threaded discussion when their schedule allows rather than facing the logistical difficulties of participating in focus groups. Pharmaceutical, biotechnology and medical device companies have embraced this method as a way of gathering vital product development and commercialization data efficiently and at low cost.
MedPanel’s full product suite now includes qualitative and quantitative custom research as well as a syndicated report series
Qualitative Custom Products:
The Med
Individual workrooms are set up so that interviews are private between the moderator/client and the respondent. Our approach enables opportunity for client follow-up and further probing questions.
Quantitative Custom Products
About MedPanel
MedPanel is a medical market intelligence company providing custom and syndicated medical market research exclusively online. MedPanel’s powerful proprietary methodology and platform enable pharmaceutical, biotechnology, medical device, diagnostics companies, as well as others with an interest in life sciences, to have greater strategic control over the development and commercialization of products, and lower costs overall. Through unparalleled access to clinicians, medical thought leaders and healthcare professionals, and through its interactive, asynchronous approach to medical panels and surveys, MedPanel is able to deliver fast, unbiased, cost-effective and actionable data. MedPanel is a global organization based in